-+ 0.00%
-+ 0.00%
-+ 0.00%

NextCell Pharma to present type 1 diabetes cell therapy program at INNODIA Symposium

PUBT·09/28/2026 07:15:29
Listen to the news
NextCell Pharma to present type 1 diabetes cell therapy program at INNODIA Symposium
  • NextCell Pharma will present its type 1 diabetes clinical development program at the INNODIA Symposium during EASD 2026 in Milan.
  • The event is scheduled for Sept. 28, 2026.
  • Management plans to highlight long-term adult data showing preserved endogenous insulin production for more than six years after a single infusion.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NextCell Pharma AB published the original content used to generate this news brief via Cision (Ref. ID: 202609280315BITN____UKPR__EN_20260925-BIT-5433-0) on September 28, 2026, and is solely responsible for the information contained therein.